(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of UBE2D3 mRNA CTD PMID:17971868 1,2-dimethylhydrazine multiple interactions ISO RGD:1553849 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2D3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1553849 6480464 1, 2-Dimethylhydrazine results in decreased expression of UBE2D3 mRNA CTD PMID:22206623 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of UBE2D3 mRNA CTD PMID:16988215 17alpha-ethynylestradiol multiple interactions ISO RGD:1553849 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2D3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1553849 6480464 Ethinyl Estradiol results in increased expression of UBE2D3 mRNA CTD PMID:17555576 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553849 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2D3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UBE2D3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553849 6480464 Tetrachlorodibenzodioxin affects the expression of UBE2D3 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1553849 6480464 Tetrachlorodibenzodioxin results in increased expression of UBE2D3 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of UBE2D3 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1344235 6480464 beta-methylcholine affects the expression of UBE2D3 mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1553849 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of UBE2D3 mRNA CTD PMID:18648102 4-hydroxynon-2-enal increases expression ISO RGD:1553849 6480464 4-hydroxy-2-nonenal results in increased expression of UBE2D3 mRNA CTD PMID:19191707 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of UBE2D3 protein CTD PMID:33236894 acrolein multiple interactions ISO RGD:1344235 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of UBE2D3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of UBE2D3 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1344235 6480464 Acrylamide results in increased expression of UBE2D3 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:1344235 6480464 Aflatoxin B1 results in decreased methylation of UBE2D3 gene CTD PMID:27153756 alpha-pinene multiple interactions ISO RGD:1344235 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of UBE2D3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of UBE2D3 mRNA CTD PMID:32699268 amiodarone increases expression ISO RGD:1344235 6480464 Amiodarone results in increased expression of UBE2D3 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UBE2D3 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1344235 6480464 Antirheumatic Agents results in decreased expression of UBE2D3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1344235 6480464 aristolochic acid I results in decreased expression of UBE2D3 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1344235 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBE2D3 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1344235 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBE2D3 mRNA CTD PMID:32525701 benzo[a]pyrene decreases expression ISO RGD:1553849 6480464 Benzo(a)pyrene results in decreased expression of UBE2D3 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1553849 6480464 Benzo(a)pyrene results in increased expression of UBE2D3 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of UBE2D3 mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1344235 6480464 7 more ... CTD PMID:20382639 Benzo[k]fluoranthene decreases expression ISO RGD:1553849 6480464 benzo(k)fluoranthene results in decreased expression of UBE2D3 mRNA CTD PMID:26377693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UBE2D3 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A decreases expression ISO RGD:1553849 6480464 bisphenol A results in decreased expression of UBE2D3 mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:1344235 6480464 bisphenol A affects the expression of UBE2D3 mRNA CTD PMID:30903817 cadmium atom decreases expression ISO RGD:1553849 6480464 Cadmium results in decreased expression of UBE2D3 mRNA CTD PMID:21467746 cadmium atom multiple interactions ISO RGD:1344235 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2D3 mRNA CTD PMID:35301059 cadmium atom increases expression ISO RGD:1344235 6480464 Cadmium results in increased expression of UBE2D3 mRNA CTD PMID:23369406 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of UBE2D3, Cadmium results in decreased expression of UBE2D3 mRNA CTD PMID:21467746 , PMID:24212999 cadmium dichloride increases expression ISO RGD:1344235 6480464 Cadmium Chloride results in increased expression of UBE2D3 mRNA CTD PMID:21457566 cadmium dichloride multiple interactions ISO RGD:1344235 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBE2D3 mRNA CTD PMID:35301059 cannabidiol increases expression ISO RGD:1344235 6480464 Cannabidiol results in increased expression of UBE2D3 mRNA CTD PMID:28025562 carbon nanotube increases expression ISO RGD:1553849 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 casticin decreases expression ISO RGD:1553849 6480464 casticin results in decreased expression of UBE2D3 mRNA CTD PMID:28444820 clofibrate multiple interactions ISO RGD:1553849 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of UBE2D3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBE2D3 mRNA] CTD PMID:17585979 copper(II) sulfate increases expression ISO RGD:1344235 6480464 Copper Sulfate results in increased expression of UBE2D3 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1553849 6480464 Asbestos, Crocidolite results in decreased expression of UBE2D3 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1553849 6480464 Cyclosporine results in decreased expression of UBE2D3 mRNA CTD PMID:19770486 dibenzo[a,l]pyrene decreases expression ISO RGD:1553849 6480464 dibenzo(a, l)pyrene results in decreased expression of UBE2D3 mRNA CTD PMID:25908611 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of UBE2D3 mRNA CTD PMID:17720352 dinophysistoxin 1 increases expression ISO RGD:1344235 6480464 dinophysistoxin 1 results in increased expression of UBE2D3 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO RGD:1553849 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of UBE2D3 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1344235 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1344235 6480464 Doxorubicin results in decreased expression of UBE2D3 mRNA CTD PMID:29803840 epoxiconazole increases expression ISO RGD:1553849 6480464 epoxiconazole results in increased expression of UBE2D3 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1344235 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBE2D3 mRNA CTD PMID:29432896 fenthion increases expression ISO RGD:1553849 6480464 Fenthion results in increased expression of UBE2D3 mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of UBE2D3 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1553849 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2D3 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1344235 6480464 Formaldehyde results in increased expression of UBE2D3 mRNA CTD PMID:20655997 genistein increases expression EXP 6480464 Genistein results in increased expression of UBE2D3 mRNA CTD PMID:17341692 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of UBE2D3 mRNA CTD PMID:33387578 hypochlorous acid increases expression ISO RGD:1553849 6480464 Hypochlorous Acid results in increased expression of UBE2D3 mRNA CTD PMID:19376150 ivermectin decreases expression ISO RGD:1344235 6480464 Ivermectin results in decreased expression of UBE2D3 protein CTD PMID:32959892 levonorgestrel multiple interactions ISO RGD:1344235 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 methylmercury chloride decreases expression ISO RGD:1344235 6480464 methylmercuric chloride results in decreased expression of UBE2D3 mRNA CTD PMID:28001369 N-acetyl-beta-D-glucosamine increases expression ISO RGD:1344235 6480464 Acetylglucosamine results in increased expression of UBE2D3 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine increases expression ISO RGD:1344235 6480464 Acetylglucosamine results in increased expression of UBE2D3 mRNA CTD PMID:18047607 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UBE2D3 mRNA CTD PMID:24136188 okadaic acid increases expression ISO RGD:1344235 6480464 Okadaic Acid results in increased expression of UBE2D3 mRNA CTD PMID:28939011 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of UBE2D3 mRNA CTD PMID:12486162 ozone multiple interactions ISO RGD:1344235 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of UBE2D3 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:1553849 6480464 Acetaminophen affects the expression of UBE2D3 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1344235 6480464 Acetaminophen results in increased expression of UBE2D3 mRNA CTD PMID:21420995 paracetamol multiple interactions ISO RGD:1553849 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of UBE2D3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBE2D3 mRNA] CTD PMID:17585979 phenobarbital decreases expression ISO RGD:1553849 6480464 Phenobarbital results in decreased expression of UBE2D3 mRNA CTD PMID:19363144 phenobarbital increases expression ISO RGD:1553849 6480464 Phenobarbital results in increased expression of UBE2D3 mRNA CTD PMID:19363144 phenylmercury acetate decreases expression ISO RGD:1344235 6480464 Phenylmercuric Acetate results in decreased expression of UBE2D3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344235 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2D3 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1344235 6480464 potassium chromate(VI) results in decreased expression of UBE2D3 mRNA CTD PMID:22714537 resveratrol decreases expression ISO RGD:1344235 6480464 resveratrol results in decreased expression of UBE2D3 mRNA CTD PMID:17804521 rotenone increases expression EXP 6480464 Rotenone results in increased expression of UBE2D3 mRNA CTD PMID:19013527 rotenone decreases expression ISO RGD:1553849 6480464 Rotenone results in decreased expression of UBE2D3 mRNA CTD PMID:23186747 SB 431542 multiple interactions ISO RGD:1344235 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate multiple interactions ISO RGD:1344235 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBE2D3 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1344235 6480464 sodium arsenite results in decreased expression of UBE2D3 mRNA CTD PMID:29301061 Soman increases expression EXP 6480464 Soman results in increased expression of UBE2D3 mRNA CTD PMID:19281266 sulforaphane multiple interactions ISO RGD:1553849 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of UBE2D3 mRNA CTD PMID:30529165 tamoxifen affects expression ISO RGD:1553849 6480464 Tamoxifen affects the expression of UBE2D3 mRNA CTD PMID:17555576 testosterone undecanoate multiple interactions ISO RGD:1344235 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 theophylline affects expression EXP 6480464 Theophylline affects the expression of UBE2D3 mRNA CTD PMID:16988215 titanium dioxide increases expression ISO RGD:1553849 6480464 titanium dioxide results in increased expression of UBE2D3 mRNA CTD PMID:23409001 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of UBE2D3 mRNA CTD PMID:19448997 trichostatin A increases expression ISO RGD:1344235 6480464 trichostatin A results in increased expression of UBE2D3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1344235 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBE2D3 mRNA CTD PMID:27188386 undecane decreases expression EXP 6480464 undecane results in decreased expression of UBE2D3 protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:1344235 6480464 Valproic Acid results in decreased expression of UBE2D3 mRNA CTD PMID:23179753 , PMID:27188386 zinc atom multiple interactions ISO RGD:1344235 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBE2D3 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1344235 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBE2D3 mRNA CTD PMID:18593933